Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Two series of MCH receptor antagonists developed at Neurocrine

Nov. 4, 2004

New factor XIa inhibitors identified by BMS researchers

Nov. 3, 2004

New Chk1 kinase inhibitors under study at Abbott

Nov. 3, 2004

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

Nov. 3, 2004

New factor Xa inhibitors in early development at Boehringer Ingelheim

Nov. 3, 2004

New CD80 antagonists and their use claimed by Avidex

Nov. 3, 2004

New vitamin D analogues and their use in bone diseases, cancer, etc.

Nov. 3, 2004

Novel Src kinase inhibitors covered by AstraZeneca patent

Nov. 3, 2004

New atherosclerosis vaccine developed by GSK team

Nov. 3, 2004

Novel CDK2/CDK5 inhibitors claimed by IRM researchers

Nov. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...